Citigroup and Goldman Sachs are advising Mentor, a maker of cosmetic surgery products, on a hostile $2.2bn (€1.9bn) bid for rival Medicis Pharmaceutical in the latest development of a takeover drama that now involves four companies.

Mentor launched a stock bid yesterday which offers Medicis shareholders a 25% premium for their shares.